THOMAS BUROKER, DO
Medical Oncology Physician · ANKENY, IA
Individual Active NPI 1982665337
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,166 | 871,989 | $40,010,408 | $19,406,807 | $15,453,617 |
| 2023 | 1,138 | 702,866 | $32,097,026 | $15,805,858 | $12,578,436 |
| 2022 | 1,197 | 692,916 | $28,087,190 | $15,391,611 | $12,270,705 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 89,600 | $55 | $44 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 71,910 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 67,720 | $31 | $24 |
| Q5125 | Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 50,580 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 46,100 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 42,260 | $2 | $1 |
| J9025 | Injection, azacitidine, 1 mg | 40,200 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 33,300 | $49 | $39 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 31,500 | $1 | $1 |
| J9306 | Injection, pertuzumab, 1 mg | 28,140 | $15 | $12 |
| J9267 | Injection, paclitaxel, 1 mg | 21,589 | $0 | $0 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 19,700 | $13 | $11 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | DO-01728 | IA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Iowa
- NPI 1184737504
- NPI 1003089814
- NPI 1952362394
- NPI 1588628101
- NPI 1891055612
- NPI 1447488325
- NPI 1386996114
- NPI 1437262086
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.